Danaher Corporation is going to buy Beckman Coulter for an estimated amount of $5.8 billion in cash said reports on Monday.
Danaher was reported to have agreed to pay $83.50 a share as a tender offer for the maker of diagnostic research equipment’s shares.
H. Lawrence Culp Jr., President and Chief Executive of Danaher said on a statement:
“Beckman Coulter is an iconic company with a great brand, broad reach and technology leadership; well positioned in the markets it serves.”
Danaher was said to have made a good pitch against other interested consortium.
On the other hand, Bob Hurley, Beckman Coulter’s President and Chief Executive said on a statement:
“Following a very comprehensive and competitive process, the board of directors voted unanimously to accept Danaher’s proposal. We believe this transaction maximizes Beckman Coulter shareholder value while strengthening the company’s position as a leader in biomedical testing to the benefit of our customers and their health care patients around the world.”
Share Some Love, Share This Post and Spread the News
Show some LOVE, Like this Page on Facebook